Precision BioSciences Inc. (NASDAQ: DTIL) activated its first clinical trial site at Arkansas Children's Hospital and began enrolling patients in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE